Determinants of Loss to Follow-Up Among MDR-TB Patients
Keywords:Tuberculosis, loss to follow-up MDR-TB, knowledge, drug side effects, family support, social stigma
Cases of tuberculosis has gotten worse since results of global surveillance revealed that mycobacterium is
resistant to rifampicin and isoniazid. It can cause Loss to Follow-Up among MDR-TB patients. The purpose
of this study is Determinants of Loss to Follow-Up among MDR-TB Patients. This research is an analytic
observational study with a case control study design with a retrospective approach. Cases were MDR-TB
patients who dropped out of treatment as much 27 people, while controls were subjects with MDR-TB
patients who did not Loss to Follow-Up of treatment as much 83 people. Data analysis was performed
by looking at the Odds Ratio value. The result showed that knowledge (OR = 5.28, 95% CI = 1.410347–
29.19908), drug side effect (OR = 32.324332, 95% CI = 4.732715–1353.07), family support (OR = 5.01875,
95% CI = 1.602489 – 15.57846), social stigma (OR = 6.712963, 95% CI = 1.473798–61.68985) were the
determinants of loss to follow up among MDR-TB patients. It can conclude that determinants of loss to
follow-up among MDR-TB patients include knowledge, drug side effects, family support, and social stigma.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Re use and mixing of content policy- We follow Creative Commons Licence Policy. We follow CC BY. Please refer below for all details
This license lets others distribute, remix, adapt, and build upon our work, even commercially, as long as they credit us for the original creation.
- The journal allows readers to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose.
- The journal allows the author(s) to hold the copyright without restrictions.
- The journal allows the author(s) to retain publishing rights without restrictions